Elevated serum immunoglobulin G levels in patients with chronic liver disease in comparison to patients with autoimmune hepatitis
- PMID: 21483590
- PMCID: PMC3071169
- DOI: 10.3402/ljm.v5i0.4857
Elevated serum immunoglobulin G levels in patients with chronic liver disease in comparison to patients with autoimmune hepatitis
Abstract
Background: Hypergammaglobulinemia is frequently observed in patients with chronic liver disease (CLD) of different causes. On the other hand, elevated levels of serum immunoglobulin G (IgG) are the best diagnostic marker for autoimmune hepatitis (AIH). Thus, the ability to distinguish AIH patients from patients with other liver disease, especially patients with advanced liver cirrhosis, is important since most AIH patients will a have favorable treatment response if diagnosed properly.
Objective: We conducted this study to evaluate the significance of elevated IgG levels in patients with non-autoimmune CLD and to compare these IgG levels with those in patients with AIH upon diagnosis.
Setting and study population: The serum IgG levels in 27 patients with AIH determined at the time of diagnosis were compared to the serum IgG levels in 27 patients with other CLDs of variable severity at the King Abdul Aziz University Hospital in Jeddah, Saudi Arabia. Severity of the disease was evaluated in all patients.
Results: We found that the patients in the CLD group with decompensated cirrhosis had significantly higher serum IgG levels compared to the compensated CLD patients (p <0.02). In addition, the AIH patients had significantly higher serum IgG levels than the non-autoimmune hepatitis CLD patients and the decompensated cirrhosis patients in the CLD group (p <0.001 and p <0.044, respectively). Most patients with elevated serum IgG of the AIH group (67%) and the CLD group (75%) had significant hypergammaglobulinemia, not just isolated elevated IgG levels.
Conclusion: Elevated serum IgG levels with hypergammaglobulinemia are commonly found in patients with advanced CLD. The differentiation of such cases from AIH is important in order to avoid misdiagnosis and confusion with AIH.
Keywords: chronic hepatitis C; compensated cirrhosis; decompensated cirrhosis; hypergammaglobulinemia.
Figures
Similar articles
-
Autoimmune hepatitis: Single-center experience of clinical presentation, response to treatment and prognosis in Saudi Arabia.Saudi J Gastroenterol. 2010 Apr-Jun;16(2):95-9. doi: 10.4103/1319-3767.61235. Saudi J Gastroenterol. 2010. PMID: 20339178 Free PMC article.
-
Features and outcome of AIH patients without elevation of IgG.JHEP Rep. 2020 Feb 29;2(3):100094. doi: 10.1016/j.jhepr.2020.100094. eCollection 2020 Jun. JHEP Rep. 2020. PMID: 32280942 Free PMC article.
-
SARS-CoV-2 infection in patients with autoimmune hepatitis.J Hepatol. 2021 Jun;74(6):1335-1343. doi: 10.1016/j.jhep.2021.01.021. Epub 2021 Jan 26. J Hepatol. 2021. PMID: 33508378 Free PMC article.
-
[Autoimmune hepatitis and overlap syndrome: diagnosis].Praxis (Bern 1994). 2002 Aug 21;91(34):1339-46. doi: 10.1024/0369-8394.91.34.1339. Praxis (Bern 1994). 2002. PMID: 12233264 Review. German.
-
Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.Hepatology. 1997 Oct;26(4):1054-66. doi: 10.1002/hep.510260438. Hepatology. 1997. PMID: 9328334 Review.
Cited by
-
Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients.Arch Med Sci. 2020 Jan 3;17(2):368-375. doi: 10.5114/aoms.2019.91451. eCollection 2021. Arch Med Sci. 2020. PMID: 33747272 Free PMC article.
-
Rational development and application of biomarkers in the field of autoimmunity: A conceptual framework guiding clinicians and researchers.J Transl Autoimmun. 2022 Mar 6;5:100151. doi: 10.1016/j.jtauto.2022.100151. eCollection 2022. J Transl Autoimmun. 2022. PMID: 35309737 Free PMC article. Review.
-
Retrospective, single-center analysis of autoimmune hepatitis in Jordanian children: clinical features, treatments, and outcomes.BMC Pediatr. 2024 Feb 8;24(1):102. doi: 10.1186/s12887-024-04590-9. BMC Pediatr. 2024. PMID: 38331749 Free PMC article.
-
Reference ranges for serum immunoglobulin (IgG, IgA, and IgM) and IgG subclass levels in healthy children.Turk J Med Sci. 2019 Apr 18;49(2):497-505. doi: 10.3906/sag-1807-282. Turk J Med Sci. 2019. PMID: 30997788 Free PMC article.
-
Diagnostic Performance of Shear-Wave Elastography in Autoimmune Hepatitis: Evaluating Baseline Characteristics and Accuracy Across Fibrosis Stages.Cureus. 2025 Jan 2;17(1):e76789. doi: 10.7759/cureus.76789. eCollection 2025 Jan. Cureus. 2025. PMID: 39897203 Free PMC article.
References
-
- Wegener M, Neuhausen P, Börsch G, Ricken D. Significance of serum immunoglobulins for the diagnosis of alcohol-induced liver diseases. Dtsch Med Wochenschr. 1986;111:1716–20. - PubMed
-
- Maruyama S, Hirayama C, Horie Y, Yorozu K, Maeda K, Inoue M, et al. Serum immunoglobulins in patients with chronic hepatitis C: a surrogate marker of disease severity and treatment outcome. Hepatogastroenterology. 2007;54:493–8. - PubMed
-
- Watt K, Uhanova J, Gong Y, Kaita K, Doucette K, Pettigrew N, et al. Serum immunoglobulins predict the extent of hepatic fibrosis in patients with chronic hepatitis C virus infection. J Viral Hepat. 2004;11:251–6. - PubMed
-
- Tanaka S, Okamoto Y, Yamazaki M, Mitani N, Nakqjima Y, Fukui H. Significance of hyperglobulinemia in severe chronic liver diseases – with special reference to the correlation between serum globulin/IgG level and ICG clearance. Hepatogastroenterology. 2007;54:2301–5. - PubMed
-
- Czaja AJ. Diagnosis and therapy of autoimmune liver disease. Med Clin North Am. 1996;80:973–94. - PubMed
LinkOut - more resources
Full Text Sources